Main Article Content
Prophylactic Antibiotics Use at IUCD Insertion and Pelvic Infection in Under 25-year old Clients in Brook Centre Jersey, United Kingdom
Abstract
Background: The Intrauterine Contraceptive Device (IUCD) is a popular method of contraception worldwide. IUCD can be used for either emergency or long-term contraception and is believed to be associated with an increased risk of pelvic infection. That risk is thought to be highest within two weeks of insertion. Therefore antibiotic administration at IUCD insertion might reduce the risk of upper genital tract infection from passive introduction of bacteria at insertion. The objective was to assess the effectiveness of prophylactic antibiotics administration at insertion in preventing pelvic infection in IUCD users.
Methodology: This is a cross-specialty retrospective review of all clients who had IUCD inserted in Brook Centre, Jersey between August 2000 and July 2008. Only the Copper-containing IUCDs were used. The Mirena Intrauterine system was not used. The antibiotic used was oral Azithromycin. (Zithromax, Pfizer). In their Sexual history, the users did not report any change in sexual partners or habits after insertion of the device. They were followed up for three months after insertion.
Results: Thirty-one clients were seen during the study period. Only one had positive preinsertion swab for Chlamydia, and only one client had clinical pelvic inflammatory disease (PID) with negative swab.
Conclusion: Pelvic infection with Chlamydia isolation was not common amongst new IUCD insertions to warrant routine antibiotic prophylaxis in Brook Jersey. All cases of pelvic infection occurred in those that received antibiotics.
Methodology: This is a cross-specialty retrospective review of all clients who had IUCD inserted in Brook Centre, Jersey between August 2000 and July 2008. Only the Copper-containing IUCDs were used. The Mirena Intrauterine system was not used. The antibiotic used was oral Azithromycin. (Zithromax, Pfizer). In their Sexual history, the users did not report any change in sexual partners or habits after insertion of the device. They were followed up for three months after insertion.
Results: Thirty-one clients were seen during the study period. Only one had positive preinsertion swab for Chlamydia, and only one client had clinical pelvic inflammatory disease (PID) with negative swab.
Conclusion: Pelvic infection with Chlamydia isolation was not common amongst new IUCD insertions to warrant routine antibiotic prophylaxis in Brook Jersey. All cases of pelvic infection occurred in those that received antibiotics.
